Results 231 to 240 of about 6,436,336 (275)
Pneumococcal community-acquired pneumonia in hospitalized adults in México 2018-2021: serotype distribution and clinical characteristics. [PDF]
Tinoco JC +14 more
europepmc +1 more source
Severe community-acquired pneumonia: an integral approach. [PDF]
Asis A +6 more
europepmc +1 more source
Corticosteroids in severe community-acquired pneumonia: friend, foe or both? [PDF]
Carpenteri F, Cilloniz C, Torres A.
europepmc +1 more source
Abstract Supplement HIV Glasgow 8–11 November 2026, Glasgow, UK/Virtual
Journal of the International AIDS Society, Volume 29, Issue S6, November 2026.
wiley +1 more source
Correction for 'Targeting Vascular Inflammation In Patients with Community-Acquired Pneumonia (TIN-CAP): protocol for a multicentre, randomised, double-blind, placebo-controlled trial'. [PDF]
europepmc +1 more source
Community-acquired pneumonia is not usually considered a high-priority problem by the public, although it is responsible for substantial mortality, with a third of patients dying within 1 year after being discharged from hospital for pneumoniae. Although up to 18% of patients with community-acquired pneumonia who were hospitalised (admitted to hospital
Marcos Restrepo +2 more
exaly +5 more sources

